From January 1, 2024 to March 31, 2024, the company has repurchased 12,971,308 shares, representing 2.43% for CNY 147.82 million. With this, the company has completed the repurchase of 20,172,808 shares, representing 3.79% for CNY 243.66 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.71 CNY | -0.57% | +4.06% | -35.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.15% | 620M | |
-2.64% | 276B | |
-8.74% | 90.65B | |
+2.25% | 41.09B | |
-10.98% | 40.86B | |
+0.42% | 38.55B | |
+0.23% | 37.81B | |
-16.27% | 30.4B | |
-4.76% | 29.32B | |
+5.87% | 23.85B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.